Dexcom breaks ground on manufacturing facility in Ireland

The Stelo glucose monitor. [Image courtesy of Dexcom]Dexcom (Nasdaq: DXCM) + announced today that it broke ground on a new state-of-the-art manufacturing facility in Ireland.

The San Diego-based continuous glucose monitor (CGM) maker announced plans to invest $325 million in Athenry last May. Breaking ground on the facility marks the first steps toward bringing more than 1,000 jobs to the area. The company expects the factory to be completely built by the second half of 2025.

Dexcom EVP of Global Operations, Barry Regan, explained what attracted the company to the growing medtech hub last year. The company says its investment represents one of the biggest single private sector investments ever in the West of Ireland. Dexcom is the latest CGM maker to break ground in Ireland, as Abbott began construction on a Kilkenny FreeStyle Libre manufacturing plant last April.

Get the full story at o…

Read more
  • 0

‘A safe pair of hands’ — Medtech’s investment in Ireland continues to grow

Killilagh, Ireland. [Image by Sean Whooley]Medtech established its presence in Ireland many years ago and still, companies continue to invest in the ever-growing country.

Boston Scientific established operations in Ireland in 1994, while Abbott has more than 70 years in the country. Medtronic, now officially headquartered in Dublin, has spent more than 40 years in Ireland and even hosted its 2023 annual meeting in the country.

Those companies, plus many more, continue to invest in Ireland, while more big names in medtech are coming to the table. Dexcom, for instance, earlier this year chose Athenry as its first European manufacturing location with a more than $325 million investment.

Speaking to MassDevice, Dexcom EVP of Global Operations, Barry Regan, explained what attracted the company to the growing medtech hub.

“One way I would describe Ireland when it comes to medtech operations and manufacturing is it’s a safe pair of hands,”…

Read more
  • 0

Boston Scientific reportedly set to add 400 jobs in Ireland

Boston Scientific (NYSE:BSX) is reportedly planning a new investment in Ireland that would create more than 400 jobs.

The Irish Examiner reports that the new investment in Clonmel, County Tipperary, totals $86.3 million (€80 million). Marlborough, Massachusetts-based Boston Scientific plans to expand its manufacturing and R&D capabilities at its existing Clonmel site, the report says.

According to the report, the company already began recruitment for new roles across “a variety of areas.” According to London-based recruitment firm Zenopa, Boston Scientific seeks candidates who specialize in engineering, manufacturing, supply, quality and discovery.

The new investment increases office and manufacturing space in Clonmel, according to the report. It also aims to transition the entire facility to source more than 90% of its energy needs from renewable sources.

“Our growth in the region has been possible thanks to our…

Read more
  • 0

Why are so many medical device companies making big investments in Ireland?

[Image from Ainars Djatlevskis on Unsplash] The foreign direct investment agency for Ireland has some of the biggest names in medtech investing in the country.

Within recent years, a number of major medtech companies celebrated anniversaries. Abbott’s was 70 years, Medtronic’s was 40 and Boston Scientific’s was 25.

That’s how long those companies have operated in Ireland.

Gerard Kilcommins, Medtronic VP of global manufacturing, vascular therapies and implants and country director in Ireland, said in a report earlier this year that its 40-year anniversary represents “an important milestone” in the company’s history.

“Our sites in Ireland have played a significant role in Medtronic’s evolution from medical device manufacturer to a global leader in healthcare technology,” Kilcommins said in July.

Each of those three companies, plus many more big names in medtech, choose Ireland for a broad range of inve…

Read more
  • 0